H.R. 10887

Protecting Consumer Access to Generic Drugs Act of 2026

Sponsor: Seth Magaziner · 0 cosponsors

Where it stands

Introduced Oct 22
Committee Now
House of Representatives —
Senate —
Law —

Introduced Oct 22
Committee Now
House of Representatives —
Senate —
Law —

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (Oct 22)

Votes

No roll-call votes yet.

Official summary

No official summary yet.

Text of the bill

Expand all

Sec. 1. Short title

Sec. 2. Unlawful agreements

Sec. 3. Notice and certification of agreements

Sec. 4. Forfeiture of 180-day exclusivity period

Section 505(j)(5)(D)(i)(V) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355(j)(5)(D)(i)(V)) is amended by inserting section 2 of the Protecting Consumer Access to Generic Drugs Act of 2026 or after that the agreement has violated.

Sec. 5. Commission litigation authority

Sec. 6. Statute of limitations